pyrroles has been researched along with Meningioma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angenstein, F; John, P; Kesseler, C; Kirches, E; Liebich, J; Mawrin, C; Sahm, F; Sandalcioglu, IE; Scherlach, C; Schnabel, S; Waldt, N | 1 |
| Burghardt, I; Lindemann, JP; Regli, L; Roth, P; Rushing, EJ; Sahm, F; Schuknecht, B; von Deimling, A; Weller, M | 1 |
| Albert, FK; Baumgarten, P; Brokinkel, B; Ebel, H; Harter, PN; Hasselblatt, M; Mittelbronn, M; Plate, KH; Stummer, W; Zachskorn, C; Zinke, J | 1 |
| Abrey, LE; Batchelor, T; DeAngelis, LM; Drappatz, J; Gavrilovic, I; Haidar, S; Kaley, TJ; Karimi, S; Lassman, AB; Lee, EQ; Ligon, K; Nolan, CP; Norden, A; Omuro, A; Plotkin, SR; Purow, B; Schiff, D; Wen, P | 1 |
| Rahman, A | 1 |
| Marosi, C | 1 |
| Adeduntan, R; Antoni, D; Noël, G; Paix, A; Waissi, W | 1 |
| Hamada, JI; Hasegawa, T; Hayashi, Y; Ikeda, C; Kawahara, Y; Kita, D; Nakada, M; Nakanuma, Y; Obuchi, W; Ohtsuki, S; Sabit, H; Sato, Y; Terasaki, T; Watanabe, T; Yoshikawa, A | 1 |
| Andrae, N; Haase, D; Hartig, R; Kalinski, T; Keilhoff, G; Kirches, E; Mawrin, C | 1 |
| Pfister, C; Pfrommer, H; Roser, F; Tatagiba, MS | 1 |
1 review(s) available for pyrroles and Meningioma
| Article | Year |
|---|---|
Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Combined Modality Therapy; Female; Humans; Ilium; Indoles; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Neoplasm Grading; Pyrroles; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Ribs; Spinal Cord Compression; Spinal Neoplasms; Spine; Sunitinib | 2017 |
2 trial(s) available for pyrroles and Meningioma
| Article | Year |
|---|---|
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cohort Studies; Disease-Free Survival; Female; Humans; Indoles; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Pyrroles; Sunitinib; Treatment Outcome | 2015 |
Sunitinib for atypical and anaplastic meningioma.
Topics: Angiogenesis Inhibitors; Confidence Intervals; Disease-Free Survival; Female; Follow-Up Studies; Humans; Indoles; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Pyrroles; Single-Blind Method; Sunitinib; Survival Analysis; Time Factors; Treatment Outcome | 2014 |
7 other study(ies) available for pyrroles and Meningioma
| Article | Year |
|---|---|
AKT1
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Humans; Meningeal Neoplasms; Meningioma; Mice; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Skull Base Neoplasms | 2022 |
Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363.
Topics: Adult; Antineoplastic Agents; Female; Humans; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Mutation; Neoplasm Grading; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Tumor Cells, Cultured | 2017 |
Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Immunohistochemistry; In Situ Hybridization; Indoles; Male; Meningioma; Middle Aged; Pyrroles; Sunitinib; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
Light at the end of the tunnel: towards an effective drug therapy for surgery- and radiation-refractory meningioma.
Topics: Antineoplastic Agents; Female; Humans; Indoles; Male; Meningeal Neoplasms; Meningioma; Pyrroles | 2015 |
Recurrent anaplastic meningioma treated by sunitinib based on results from quantitative proteomics.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Female; Humans; Immunohistochemistry; Indoles; Meningeal Neoplasms; Meningioma; Middle Aged; Molecular Targeted Therapy; Proteomics; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Spectrometry, Mass, Electrospray Ionization; Sunitinib | 2012 |
Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cells.
Topics: Angiogenesis Inhibitors; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; DNA; Dose-Response Relationship, Drug; fms-Like Tyrosine Kinase 3; Humans; Indoles; Meningeal Neoplasms; Meningioma; Protein Kinase Inhibitors; Pyrroles; Radiation Tolerance; Receptors, Platelet-Derived Growth Factor; Sunitinib | 2012 |
Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.
Topics: Angiogenic Proteins; Cell Proliferation; Humans; Indoles; Meningeal Neoplasms; Meningioma; Neovascularization, Pathologic; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-sis; Pyrroles; Quinazolines; Receptor, Platelet-Derived Growth Factor beta; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sunitinib; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor A; Xanthones | 2012 |